Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutationsPawel Buczkowicz, Michael Brudno, Jennifer Zuccaro et al.|Nature Genetics|2014Cited by 654
Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry studySara Khan, Kuo-Sheng Wu, Palma Solano‐Páez et al.|The Lancet Child & Adolescent Health|2021Cited by 41
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A. Upadhyaya, Amar Gajjar, Olivia Campagne et al.|Neuro-Oncology|2022Cited by 29
HGG-32. PNOC008: A PILOT TRIAL TESTING THE CLINICAL BENEFIT OF USING MOLECULAR PROFILING TO DETERMINE AN INDIVIDUALIZED TREATMENT PLAN IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA (EXCLUDING DIFFUSE INTRINSIC PONTINE GLIOMA)Andrea Franson, Sabine Mueller, Lindsay Kilburn et al.|Neuro-Oncology|2024Cited by 2
Clinical phenotypes and prognostic features of ETMRs (Embryonal Tumor with Multi-layered Rosettes) a new CNS tumor entity: A Rare Brain Tumor Registry studySara Khan, Jennifer A. Chan, Palma Solano‐Páez et al.|medRxiv|2020Cited by 1